Announcements Trials

Browse Landscape

Phase

Status

Recruiting 14 Active not recruiting 7 Not yet recruiting 2 Terminated 1 Enrolling by invitation 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 13 Nivolumab 6 Cyclophosphamide 6 Carboplatin 6 Specimen Handling 5 Pemetrexed 5 Paclitaxel 5 Docetaxel 5 Cisplatin 5 Cetuximab 5 Bevacizumab 5 fludarabine phosphate 4 fludarabine 4 atezolizumab 4 tislelizumab 3 durvalumab 3 Standard of Care 3 Practice Guidelines as Topic 3 Methods 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 Gemcitabine 3 Educational Status 3 Early Intervention, Educational 3 130-nm albumin-bound paclitaxel 3 venetoclax 2 tremelimumab 2 temsirolimus 2 niraparib 2 ixazomib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × sacituzumab govitecan × 30 days × Clear all

NCT03337698 2026-05-12

Morpheus Lung

Hoffmann-La Roche

Phase 1/2 Terminated

314 enrolled 31 charts

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡